BIIB

Biogen Inc  (BIIB) Q4 2019 earnings call dated Jan. 30, 2020 Corporate Participants: Joe Mara — Vice President, Investor Relations Michel Vounatsos — Chief…

— Biogen Inc. (NASDAQ: BIIB) reported its fourth-quarter 2019 adjusted earnings of $8.34 per share versus $8.02 per share expected.…

Biogen Inc. (NASDAQ: BIIB) reported a 7% increase in earnings for the third quarter of 2019 as spinal muscular atrophy…

The market value of pharma giant Biogen, Inc. (NASDAQ: BIIB) declined by a third in March when the stock suffered…